Credit Suisse’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4.73M | Sell |
51,288
-14,689
| -22% | -$1.38M | ﹤0.01% | 1327 |
|
|
2023
Q4 | $6.27M | Buy |
65,977
+13,132
| +25% | +$1.23M | 0.01% | 1203 |
|
|
2023
Q3 | $4.94M | Sell |
52,845
-293,966
| -85% | -$27.2M | 0.01% | 1277 |
|
|
2023
Q2 | $31.7M | Sell |
346,811
-185,973
| -35% | -$15.3M | 0.03% | 535 |
|
|
2023
Q1 | $39.2M | Buy |
532,784
+1,156
| +0.2% | +$100K | 0.04% | 467 |
|
|
2022
Q4 | $44.4M | Buy |
531,628
+6,797
| +1% | +$613K | 0.05% | 428 |
|
|
2022
Q3 | $50.8M | Buy |
524,831
+16,765
| +3% | +$2M | 0.06% | 364 |
|
|
2022
Q2 | $53.4M | Buy |
508,066
+8,073
| +2% | +$1.03M | 0.06% | 361 |
|
|
2022
Q1 | $86.1M | Buy |
499,993
+42,209
| +9% | +$6.31M | 0.07% | 291 |
|
|
2021
Q4 | $74.1M | Sell |
457,784
-6,082
| -1% | -$977K | 0.04% | 477 |
|
|
2021
Q3 | $69.2M | Buy |
463,866
+324,806
| +234% | +$67.5M | 0.04% | 504 |
|
|
2021
Q2 | $34.1M | Buy |
139,060
+96,527
| +227% | +$25.3M | 0.02% | 873 |
|
|
2021
Q1 | $11.3M | Buy |
42,533
+5,095
| +14% | +$1.44M | 0.01% | 1503 |
|
|
2020
Q4 | $11M | Buy |
37,438
+347
| +0.9% | +$89K | 0.01% | 1518 |
|
|
2020
Q3 | $8.77M | Buy |
37,091
+4,381
| +13% | +$996K | 0.01% | 1452 |
|
|
2020
Q2 | $6.49M | Sell |
32,710
-3,631
| -10% | -$677K | ﹤0.01% | 1542 |
|
|
2020
Q1 | $6.67M | Sell |
36,341
-8,141
| -18% | -$1.45M | 0.01% | 1387 |
|
|
2019
Q4 | $7.43M | Buy |
44,482
+16,660
| +60% | +$2.48M | 0.01% | 1597 |
|
|
2019
Q3 | $3.65M | Sell |
27,822
-588
| -2% | -$76.5K | ﹤0.01% | 2008 |
|
|
2019
Q2 | $3.45M | Sell |
28,410
-46,044
| -62% | -$5.46M | ﹤0.01% | 2040 |
|
|
2019
Q1 | $9.18M | Buy |
74,454
+18,698
| +34% | +$2.35M | 0.01% | 1291 |
|
|
2018
Q4 | $6.53M | Buy |
55,756
+24,601
| +79% | +$2.9M | 0.01% | 1409 |
|
|
2018
Q3 | $3.89M | Buy |
31,155
+5,900
| +23% | +$652K | ﹤0.01% | 1866 |
|
|
2018
Q2 | $2.16M | Sell |
25,255
-3,820
| -13% | -$281K | ﹤0.01% | 2386 |
|
|
2018
Q1 | $1.75M | Sell |
29,075
-24,577
| -46% | -$1.4M | ﹤0.01% | 2533 |
|
|
2017
Q4 | $2.83M | Buy |
53,652
+16,807
| +46% | +$886K | ﹤0.01% | 2174 |
|
|
2017
Q3 | $2.06M | Sell |
36,845
-34,065
| -48% | -$1.8M | ﹤0.01% | 2524 |
|
|
2017
Q2 | $4.45M | Sell |
70,910
-14,500
| -17% | -$844K | ﹤0.01% | 1699 |
|
|
2017
Q1 | $4.36M | Sell |
85,410
-22,201
| -21% | -$1.06M | ﹤0.01% | 1757 |
|
|
2016
Q4 | $4.59M | Buy |
107,611
+39,269
| +57% | +$1.67M | ﹤0.01% | 1712 |
|
|
2016
Q3 | $3.24M | Buy |
68,342
+9,692
| +17% | +$484K | ﹤0.01% | 2007 |
|
|
2016
Q2 | $2.96M | Buy |
58,650
+2,444
| +4% | +$123K | ﹤0.01% | 2035 |
|
|
2016
Q1 | $2.72M | Buy |
56,206
+32,061
| +133% | +$1.24M | ﹤0.01% | 1979 |
|
|
2015
Q4 | $949K | Buy |
24,145
+134
| +0.6% | +$5.36K | ﹤0.01% | 2858 |
|
|
2015
Q3 | $912K | Sell |
24,011
-57,489
| -71% | -$2.42M | ﹤0.01% | 2893 |
|
|
2015
Q2 | $3.24M | Buy |
81,500
+27,842
| +52% | +$868K | ﹤0.01% | 2140 |
|
|
2015
Q1 | $1.44M | Sell |
53,658
-29,779
| -36% | -$840K | ﹤0.01% | 2683 |
|
|
2014
Q4 | $2.45M | Buy |
83,437
+114
| +0.1% | +$2.81K | ﹤0.01% | 2376 |
|
|
2014
Q3 | $1.68M | Sell |
83,323
-38,328
| -32% | -$739K | ﹤0.01% | 2628 |
|
|
2014
Q2 | $2.04M | Buy |
121,651
+101,606
| +507% | +$1.44M | ﹤0.01% | 2691 |
|
|
2014
Q1 | $298K | Sell |
20,045
-36,041
| -64% | -$555K | ﹤0.01% | 4110 |
|
|
2013
Q4 | $820K | Buy |
56,086
+12,075
| +27% | +$194K | ﹤0.01% | 3437 |
|
|
2013
Q3 | $757K | Sell |
44,011
-25,160
| -36% | -$373K | ﹤0.01% | 3179 |
|
|
2013
Q2 | $803K | Buy |
+69,171
| New | +$792K | ﹤0.01% | 2966 |
|
Other funds holding AMED
AAM
FCM
WCMNY
WIC
Credit Suisse's AMED Position: Q1 2024 in Review
Credit Suisse reduced its Amedisys (AMED) stake by 22% in Q1 2024, selling an estimated $1.38M and leaving 51,288 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1327.
Credit Suisse first reported a position in AMED in Q2 2013 and has held it in 44 quarters since. The position peaked at $86.1M in Q1 2022. 284 funds tracked by Wall St. Rank hold AMED as of Q1 2024.
- Credit Suisse held 51,288 shares of Amedisys worth $4.73M as of Q1 2024.
- Credit Suisse sold 14,689 Amedisys shares in Q1 2024, an estimated $1.38M.
- Amedisys made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1327 holding.
- Credit Suisse first reported a position in Amedisys in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Amedisys position peaked at $86.1M in Q1 2022.
- 284 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.